ICB_8271
ICB Medical AD Check™
Recommended for
- Recommend for aged 40 and above
- Family History of AD
- High-risk Factors of AD:Hypertension, high blood sugar, high cholesterol, history of stroke, or previous brain injuries
- APOE4 Gene Carriers
- Depression/Living with High Stress
- Smoking or Heavy Drinking
- Sign of Cognitive Decline is Observed
Blood Check
-
p-Tau217
Report
-
Report interpreted and explained by Professional Scientist team via phone
AD Check™ Use of Technology [Please check the PDF for more details]
Simoa - Single Molecule Array
Simoa is an ultra-sensitive biomarker detection method that can detect extremely low concentrations of p-Tau217 protein in plasma. This testing method has received breakthrough medical device designation from the U.S. FDA[1], and international clinical literature confirms that it has high sensitivity and specificity.
Advantages - Extensive medical literatures and clinical studies show p-Tau217 effectively detects
Alzheimer's Disease (AD)
(1) Use of Technology: Breakthrough Device Designation granted by US FDA
(2) High accuracy, specificity, and sensitivity
(3) Simple blood test, non-invasive
(4) Test by local accredited laboratory
AD Check認知測™ uses a breakthrough medical technology that has been clinically validated and recognized by the U.S. Food and Drug Administration (FDA) to accurately detect the levels of a biomarker related to Alzheimer’s Disease (AD) pathology in the blood: phosphorylated Tau217 protein (p-Tau217). This helps assess the risk of Alzheimer’s Disease (AD) pathology and allows for regular monitoring of risk changes as individuals age.
Please click here for more details.
Research further indicates that the testing technology used in AD Check™ is consistent with the results of traditional positron emission tomography (PET-Aβ, PET-Tau) and cerebrospinal fluid biomarkers (CSF Aβ42/40, and CSF p-Tau181).[2]
[2] Ashton NJ, Brum WS, Di Molfetta G, et al. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol. 2024;81(3):255–263. doi:10.1001/jamaneurol.2023.5319
ICB Medical Limited Terms and Conditions:
The confirmation email will be sent to your e-mail address immediately after successful payment. Customers will be informed within 1-2 working days. Customers also can query your transaction in the next working days. General Enquiry Hotline: 9514 8532
Age
For customers aged 18 or above
Validity
Health Checkup Package with 1 year validity. Registration must be completed within 1 year (counting from the date of payment confirmation). Reservations are taken one month in advance. Invalid exceeds the period.
Report
Under normal circumstances, all medical reports will be ready around 10-14 working days (excluding Saturday, Sunday and public holiday). A delay in processing some requests due to the following reasons: 1. indicate the specific selective 2. Some items take more time for test
A. Local / Oversea customers (Choose one)
1. Call report & electronic report
2. Call report & *Post
*Post Fee
Local mail $15; Registration$30
B. Oversea customers
1. Electronic Report (via email)
Remarks
a. Customers can get one free call or face to face explanation. Otherwise, customers would be charged an additional fee of $230
b. All medical records will be destroyed after 3 months. Please note an administration fee may be charged $150 for additional copies. We make no warranties regarding completeness of report copies.
c. If they choose mailing report, then they do so at their own risk.
d. All tests are not for the purpose of medical diagnosis or treatment. If patients require a letter of referral from a doctor, we're entitled to charge $230 for this service.
Disclaimers
All health check/health screening services are not for the purpose of medical diagnostic or therapeutic purposes. When there is any sign of symptom/disease in your health, please consult Doctor immediately for diagnosis and treatment.